Implantable Sensor Market is expected to reach US$ 11,415.62 Mn by Analog Devices, Inc.; DEXCOM, INC.; Glusense Ltd.; Honeywell International Inc.; Medtronic; NXP SEMICONDUCTORS N.V.; Pinnacle Technology Inc.; Sensirion AG; TE Connectivity; and Texas Inst

According to our latest study on “Implantable Sensor Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Application and End User,” the market was valued at US$ 4,912.00 million in 2019 and it is projected to reach US$ 11,415.62 million by 2027; it is expected to grow at a CAGR of 11.1% during 2020–2027. The report highlights trends prevailing in the global implantable sensor market, and the factors driving and restraining the market growth.

Get a Sample Copy of the Report@ https://www.theinsightpartners.com/sample/TIPRE00016982/?openpr-10225

Based on type, the global implantable sensor market is segmented into glucose sensor, temperature sensor, oxygen sensor, pressure sensor, and others. In 2019, the glucose sensor segment accounted for the highest share of the market. The growth for this segment is attributed to growing cases of diabetes coupled with increasing adoption of continuous glucose monitoring (CGM) devices.

The growth of the implantable sensor market is driven by increasing prevalence of chronic diseases and growing adoption of mobile healthcare technologies. However, low rate of adoption in emerging countries is the major factors hindering the market growth. Analog Devices, Inc.; DEXCOM, INC.; Glusense Ltd.; Honeywell International Inc.; Medtronic; NXP SEMICONDUCTORS N.V.; Pinnacle Technology Inc.; Sensirion AG; TE Connectivity; and Texas Instruments Incorporated are among the major companies operating in the market.

Market Insights

Growing Adoption of Mobile Healthcare Technologies

Mobile healthcare technologies offer a great potential for improving patient care and reducing healthcare costs. Implantable and wearable technologies subsidize to a transformation in the mobile health era in terms of improving healthcare and health outcomes and providing real-time management on enhanced health management and tracking. Further, mobile technologies are paving the way for revolutionizing the diagnosis of diseases and monitoring patient treatment. Mobile sensors are helping in everything from monitoring our movements and sleeps to record the electrical activity in our hearts 24/7 as we go about our daily routines. As a result, the technology is quickly becoming vital for researching ways to cure illness and improve health.

Most cardiac rhythm management companies have applications that physicians and device technicians can access to track their patients with pacemakers and implantable cardioverter defibrillators, enrolled in remote patient management programs. All current-generation cardiac rhythm management devices are capable of remote transmission. Newer pacemakers and implantable cardioverter-defibrillators have Bluetooth LE transmission capability to create a straightforward way to share device data to patient-centered applications. As all cardiac rhythm management companies have built secure data platforms to receive remotely transmitted implanted device data, there is an opportunity to expand these platforms and include patient-facing software applications. The new generation of implantable hemodynamic sensors for heart failure management provides web- and app-based data to physicians to allow for physician-directed patient self-management of remotely transmitted intracardiac pressures.

Implantable devices or electronics have rapidly entered the area of digital health in various biomedical applications, including monitoring, tracking, and recording the vital signs of people to improve their health and that of their family.

The report segments global implantable sensor market as follows:

By Type

Glucose Sensor
Temperature Sensor
Oxygen Sensor
Pressure Sensor
Others

By Application

Medical Diagnostic
Clinical Therapy
Personal Healthcare
Imaging

By End User

Hospitals
Clinics
Diagnostic Center

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of Middle East & Africa
South and Central America (SCAM)
Brazil
Argentina
Rest of South and Central America

Purchase a Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00016982/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.